A Novel Immunotherapy Construct for ALL: STAR-T Cell Therapy for Relapsed/Refractory B-Cell ALL

Lu, PH

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021; 21 (): S88